Novo Integrated Sciences Inc (NVOS)
0.5852
+0.02
(+4.28%)
USD |
NASDAQ |
May 09, 16:00
0.5852
0.00 (0.00%)
After-Hours: 20:00
Novo Integrated Sciences Net Income (Quarterly): -2.746M for Feb. 29, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| February 29, 2024 | -2.746M |
| November 30, 2023 | -4.680M |
| August 31, 2023 | -3.160M |
| May 31, 2023 | -1.497M |
| February 28, 2023 | -4.621M |
| November 30, 2022 | -3.935M |
| August 31, 2022 | -22.43M |
| May 31, 2022 | -3.810M |
| February 28, 2022 | -4.805M |
| November 30, 2021 | -1.807M |
| August 31, 2021 | -1.940M |
| May 31, 2021 | -0.4112M |
| February 28, 2021 | -1.340M |
| November 30, 2020 | -0.7715M |
| August 31, 2020 | -4.224M |
| May 31, 2020 | -0.0983M |
| February 29, 2020 | -0.5045M |
| November 30, 2019 | -0.0881M |
| August 31, 2019 | 0.0782M |
| May 31, 2019 | -0.0993M |
| February 28, 2019 | -0.1195M |
| November 30, 2018 | -0.2514M |
| August 31, 2018 | -0.1583M |
| May 31, 2018 | -0.2179M |
| February 28, 2018 | -1.375M |
| Date | Value |
|---|---|
| November 30, 2017 | -0.3573M |
| August 31, 2017 | -0.2864M |
| May 31, 2017 | -0.3567M |
| March 31, 2017 | -0.037M |
| December 31, 2016 | -0.0425M |
| September 30, 2016 | -0.0373M |
| June 30, 2016 | -0.017M |
| March 31, 2016 | -0.0681M |
| December 31, 2015 | -0.0354M |
| September 30, 2015 | -0.0133M |
| June 30, 2015 | -0.3623M |
| March 31, 2015 | -2.360M |
| December 31, 2014 | -0.3283M |
| September 30, 2014 | -0.2089M |
| June 30, 2014 | -0.3505M |
| March 31, 2014 | -0.1459M |
| December 31, 2013 | -0.1924M |
| September 30, 2013 | -0.1695M |
| June 30, 2013 | -0.2833M |
| March 31, 2013 | -0.2426M |
| December 31, 2012 | -0.1652M |
| September 30, 2012 | -0.1989M |
| June 30, 2012 | -0.3855M |
| March 31, 2012 | -0.4086M |
| December 31, 2011 | -0.4171M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-22.43M
Minimum
Aug 2022
0.0782M
Maximum
Aug 2019
-3.144M
Average
-1.873M
Median
Net Income (Quarterly) Benchmarks
| American Shared Hospital Services | 0.415M |
| Astrana Health Inc | 12.36M |
| Cryo-Cell International Inc | 0.5562M |
| P3 Health Partners Inc | -25.46M |
| Biote Corp | 7.734M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 3.171M |
| Total Expenses (Quarterly) | 4.710M |
| EPS Diluted (Quarterly) | -0.16 |
| Enterprise Value | 13.02M |
| Gross Profit Margin (Quarterly) | 41.76% |
| Profit Margin (Quarterly) | -86.61% |
| Earnings Yield | -109.4% |
| Normalized Earnings Yield | -116.13 |